The S2010 research study is enrolling women with stage 1, 2, or 3 hormone receptor-positive breast cancer. It tests whether monitoring endocrine therapy side effects more often can help reduce these symptoms.
#breastcancer#endocrinetherapy#cancertreatment
Do you have metastatic breast cancer and a new prescription for a CDK4/6 inhibitor? If so, you may be eligible to participate in clinical trial EAQ221CD/CONCURxP.
Learn more here: https://t.co/PxKgIPsCBU
#breastcancer#cancertreatment#clinicaltrial